These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2465792)

  • 41. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.
    Iatridis PG; Gadarowski JJ; Iatridis SG
    Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
    Bouma BN; Miles LA; Beretta G; Griffin JH
    Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
    Gordon EM; Ratnoff OD; Goldsmith GH
    J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue-type) plasminogen activator.
    Allen RA; Kluft C; Brommer EJ
    Eur J Clin Invest; 1984 Oct; 14(5):354-61. PubMed ID: 6437833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis.
    Ewald GA; Eisenberg PR
    Circulation; 1995 Jan; 91(1):28-36. PubMed ID: 7805216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
    Takada Y; Takada A
    Thromb Res; 1979; 16(5-6):865-9. PubMed ID: 160629
    [No Abstract]   [Full Text] [Related]  

  • 49. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of the plasma kallikrein/kinin system on endothelial cells.
    Rojkjaer R; Schmaier AH
    Proc Assoc Am Physicians; 1999; 111(3):220-7. PubMed ID: 10354362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP; Meier HL; Mandle R
    Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of dilution, pH and ionic strength of plasma on t-PA precipitation in euglobulin fraction.
    Hong SY; Shin HK; Yang DH
    Korean J Intern Med; 1992 Jul; 7(2):73-80. PubMed ID: 1306075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
    Bouma BN; Griffin JH
    J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.
    Kluft C; Cooper P; Jie AF; Lowe GD; Forbes CD; Blamey SL; van de Putte LB
    Haemostasis; 1985; 15(2):144-50. PubMed ID: 3874124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors.
    Haire WD; Goldsmith JC; Rasmussen J
    Am J Hematol; 1989 May; 31(1):36-40. PubMed ID: 2495714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrinolysis in the rat after short-term aspirin therapy.
    Housholder GT; Moorrees LL
    J Oral Surg; 1980 Jun; 38(6):412-6. PubMed ID: 6929324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simple and rapid method to study the association of the contact proteins of blood coagulation.
    Katcher HL; Samuel M; Villanueva GB
    Thromb Res; 1992 Dec; 68(6):443-50. PubMed ID: 1341054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous versus intraperitoneal administration of dextran in the rabbit: effects on fibrinolysis.
    Wagaman R; Ingram JM; Rao PS; Saba HI
    Am J Obstet Gynecol; 1986 Sep; 155(3):464-70. PubMed ID: 2428247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):314-20. PubMed ID: 6154406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.